Ovid Therapeutics Inc. Revenue 2020–2025
Ovid Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ovid Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Ovid Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 6.5 M, a 990.82% increase year-over-year.
- Ovid Therapeutics Inc. annual revenue for 2025 was 7.3 M, a 1181.27% increase from 2024.
- Ovid Therapeutics Inc. annual revenue for 2024 was 566000, a 44.39% increase from 2023.
- Ovid Therapeutics Inc. annual revenue for 2023 was 392000, a 73.91% decrease from 2022.
- Ovid Therapeutics Inc. annual revenue for 2022 was 1.5 M.
Ovid Therapeutics Inc. (OVID) — Frequently Asked Questions
Ovid Therapeutics Inc. (OVID) is a publicly traded US company. It has a market capitalization of $288M. In fiscal 2025 it reported revenue of $7M and net income of -$17M. Explore OVID's stock price, financial statements, earnings history, margins and key ratios below.
What is Ovid Therapeutics Inc.'s market cap?
Ovid Therapeutics Inc. (OVID) has a market capitalization of $288M.
What is the OVID stock price?
OVID trades at $2.21 (-3.07% on the day).
How much revenue does Ovid Therapeutics Inc. make?
Ovid Therapeutics Inc. reported revenue of $7M in fiscal 2025.
Is OVID profitable?
In fiscal 2025, Ovid Therapeutics Inc. reported net income of -$17M.